Thomas DL - Search Results

1

Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic.

Mehta SH, Lucas GM, Mirel LB, Torbenson M, Higgins Y, Moore RD, Thomas DL, Sulkowski MS. Mehta SH, et al. Among authors: thomas dl. AIDS. 2006 Nov 28;20(18):2361-9. doi: 10.1097/QAD.0b013e32801086da. AIDS. 2006. PMID: 17117023

2

Epidemiology of hepatitis E virus infection in Turkey.

Thomas DL, Mahley RW, Badur S, Palaoglu KE, Quinn TC. Thomas DL, et al. Lancet. 1993 Jun 19;341(8860):1561-2. doi: 10.1016/0140-6736(93)90698-g. Lancet. 1993. PMID: 8099641 Free article.

3

Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users.

Thomas DL, Shih JW, Alter HJ, Vlahov D, Cohn S, Hoover DR, Cheung L, Nelson KE. Thomas DL, et al. J Infect Dis. 1996 Oct;174(4):690-5. doi: 10.1093/infdis/174.4.690. J Infect Dis. 1996. PMID: 8843204

4

Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection.

Thomas DL, Vlahov D, Alter HJ, Hunt JC, Marshall R, Astemborski J, Nelson KE. Thomas DL, et al. J Infect Dis. 1998 Mar;177(3):539-42. doi: 10.1086/514245. J Infect Dis. 1998. PMID: 9498429

5

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection.

Sulkowski MS, Thomas DL, Chaisson RE, Moore RD. Sulkowski MS, et al. Among authors: thomas dl. JAMA. 2000 Jan 5;283(1):74-80. doi: 10.1001/jama.283.1.74. JAMA. 2000. PMID: 10632283

6

Screening for hepatitis C virus in human immunodeficiency virus-infected individuals.

Thio CL, Nolt KR, Astemborski J, Vlahov D, Nelson KE, Thomas DL. Thio CL, et al. Among authors: thomas dl. J Clin Microbiol. 2000 Feb;38(2):575-7. doi: 10.1128/JCM.38.2.575-577.2000. J Clin Microbiol. 2000. PMID: 10655348 Free PMC article.

7

Determinants of the quantity of hepatitis C virus RNA.

Thomas DL, Astemborski J, Vlahov D, Strathdee SA, Ray SC, Nelson KE, Galai N, Nolt KR, Laeyendecker O, Todd JA. Thomas DL, et al. J Infect Dis. 2000 Mar;181(3):844-51. doi: 10.1086/315314. J Infect Dis. 2000. PMID: 10720503

8

Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus.

Sulkowski MS, Mast EE, Seeff LB, Thomas DL. Sulkowski MS, et al. Among authors: thomas dl. Clin Infect Dis. 2000 Apr;30 Suppl 1:S77-84. doi: 10.1086/313842. Clin Infect Dis. 2000. PMID: 10770916 Review.

9

The natural history of hepatitis C virus infection: host, viral, and environmental factors.

Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, Nolt K, Nelson KE, Strathdee SA, Johnson L, Laeyendecker O, Boitnott J, Wilson LE, Vlahov D. Thomas DL, et al. JAMA. 2000 Jul 26;284(4):450-6. doi: 10.1001/jama.284.4.450. JAMA. 2000. PMID: 10904508

10

Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States.

Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Mehta SH, et al. Among authors: thomas dl. Ann Intern Med. 2000 Oct 17;133(8):592-9. doi: 10.7326/0003-4819-133-8-200010170-00009. Ann Intern Med. 2000. PMID: 11033586

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

769 results

Search Page

Filters